Education and skills training for healthcare providers on HPV
Implementing Innovative and Strategic Approaches to Prevent and Mitigate the Deleterious Effects of HPV Across the Lifespan of Hispanics of Mexican Origin: Healthcare Provider Intervention
This study is testing whether special training for healthcare providers in the El Paso U.S.-Mexico Border Region can help them better talk about HPV and its vaccine to encourage more people to get vaccinated.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | University of Texas, El Paso Academic / other |
| Locations | 2 sites (Las Cruces, New Mexico and 1 other locations) |
| Trial ID | NCT05120869 on ClinicalTrials.gov |
What this trial studies
This intervention focuses on healthcare providers in the El Paso U.S.-Mexico Border Region, aiming to enhance their knowledge and communication skills regarding human papillomavirus (HPV) and its vaccine. The study recruits both current and emerging healthcare professionals to participate in tailored educational sessions designed to reduce vaccine hesitancy and improve vaccination rates among the populations they serve. The intervention includes a comparison between a tailored HPV education group and a general education control group, with the goal of fostering culturally competent discussions about HPV.
Who should consider this trial
Good fit: Ideal candidates for this study are current or emerging healthcare providers working or training in the El Paso U.S.-Mexico Border Region who are authorized to recommend or administer the HPV vaccine.
Not a fit: Patients who are not affiliated with the El Paso U.S.-Mexico Border Region or who do not have access to participating healthcare providers may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could lead to increased HPV vaccination rates and improved health outcomes in the communities served by these healthcare providers.
How similar studies have performed: Other studies have shown that educational interventions for healthcare providers can effectively improve knowledge and practices regarding vaccinations, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Current (in practice) or emerging (in training - medical student, resident, or fellow) healthcare provider * Working/training or living in the El Paso U.S.-Mexico Border Region (i.e., El Paso County, TX-Southern New Mexico) * Have the authorization to recommend/prescribe/administer the HPV vaccine Exclusion Criteria: * Unaffiliated with the El Paso U.S.-Mexico Border Region (i.e., El Paso County, TX-Southern New Mexico) * Participation in Phases I or II of the larger research project \[cross-sectional phases\] * Does not identify as a current or emerging healthcare provider * Declines or is unable to participate in the full intervention and follow-up time-points * Unable to complete participation and activities in the English language
Where this trial is running
Las Cruces, New Mexico and 1 other locations
- Burrell College of Osteopathic Medicine — Las Cruces, New Mexico, United States (Recruiting)
- The University of Texas at El Paso, Border Biomedical Research Center — El Paso, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Eva M Moya, PhD, LMSW — The University of Texas at El Paso, Border Biomedical Research Center
- Study coordinator: Kristin Gosselink, PhD
- Email: kgosselink@burrell.org
- Phone: 575-674-2335
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.